These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17889115)

  • 1. Sirolimus monotherapy as maintenance immunosuppression: single-center experience in 50 kidney transplant patients.
    Arellano EM; Campistol JM; Oppenheimer F; Rovira J; Diekmann F
    Transplant Proc; 2007 Sep; 39(7):2131-4. PubMed ID: 17889115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience.
    Pinto JR; Arellano Torres EM; Franco A; Morales JM; Ruiz JC; Diekmann F; Alperovich G; Campistol JM
    Transpl Int; 2010 Mar; 23(3):307-12. PubMed ID: 19843293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.
    Steigerwalt SP; Brar N; Dhungel A; Butcher D; Steigerwalt S; El-Ghouroury M; Provenzano R
    Transplant Proc; 2009 Dec; 41(10):4184-7. PubMed ID: 20005365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
    Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus in pediatric renal transplantation.
    Ibáñez JP; Monteverde ML; Goldberg J; Diaz MA; Turconi A
    Transplant Proc; 2005 Mar; 37(2):682-4. PubMed ID: 15848500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-based immunosuppression in kidney transplantation for type 2 diabetic nephropathy.
    Veroux M; Corona D; Giuffrida G; Gagliano M; Vizcarra D; Tallarita T; Zerbo D; Giaquinta A; Sorbello M; Macarone M; Veroux P
    Urol Int; 2010; 84(3):301-4. PubMed ID: 20389159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus monotherapy: feasible immunosuppression for long-term follow-up of kidney transplantation--a pilot experience.
    Diekmann F; Gutierrez-Dalmau A; Torregrosa JV; Oppenheimer F; Campistol JM
    Transplantation; 2005 Nov; 80(9):1344-8. PubMed ID: 16314805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.
    Morard I; Dumortier J; Spahr L; Hadengue A; Majno P; Morel P; Mentha G; Giostra E
    Liver Transpl; 2007 May; 13(5):658-64. PubMed ID: 17457887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
    Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to sirolimus in pediatric renal transplantation recipients.
    Garcia CD; Bittencourt VB; Alves AB; Garcia VD; Tumelero A; Antonello JS; Malheiros D
    Transplant Proc; 2006; 38(6):1901-3. PubMed ID: 16908317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus in pediatric liver transplantation: a single-center experience.
    Gibelli NE; Tannuri U; Pinho-Apezzato ML; Tannuri AC; Maksoud-Filho JG; Andrade WC; Velhote MC; Santos MM; Ayoub AA; Marques da Silva M
    Transplant Proc; 2009 Apr; 41(3):901-3. PubMed ID: 19376384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus in chronic allograft nephropathy in pediatric recipients.
    Ibáñez JP; Monteverde ML; Diaz MA; Goldberg J; Turconi AF
    Pediatr Transplant; 2007 Nov; 11(7):777-80. PubMed ID: 17910656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
    Russ G; Jamieson N; Oberbauer R; Arias M; Murgia MG; Blancho G; Sato R; Stoeckl M; Revicki DA
    Transpl Int; 2007 Oct; 20(10):875-83. PubMed ID: 17854445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
    Benavides CA; Pollard VB; Mauiyyedi S; Podder H; Knight R; Kahan BD
    Transplantation; 2007 Jul; 84(1):83-8. PubMed ID: 17627242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to sirolimus in posttransplant renal neoplasms.
    Lopez V; Gutierrez C; Cabello M; Burgos D; Sola E; Gonzalez-Molina M
    Transplant Proc; 2007 Sep; 39(7):2264-6. PubMed ID: 17889158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus.
    Oberbauer R
    Transplantation; 2009 Apr; 87(8 Suppl):S7-10. PubMed ID: 19384186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A; Kaçar S; Erdoğdu U; Varilsüha C; Kandemir G; Karaca C; Akman F
    Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.